On July 31, 2026, 3D Systems, in collaboration with the U.S. Defense Health Agency and Walter Reed National Military Medical Center, announced a landmark regulatory breakthrough: the in-hospital 3D-printed titanium cranial plate repair system (TCP) officially received FDA 510(k) clearance (K242801). This marks the first time in FDA history that market authorization for a permanent implant has been granted to an on-site hospital production facility, rather than a traditional manufacturer's plant. The entire workflow is completed within the closed-loop system at Walter Reed Hospital: from patient CT DICOM data segmentation, 3D reconstruction of the cranial defect, topology optimization design, LPBF printing (Ti-6Al-4V ELI powder, 50 μm layer thickness), vacuum stress-relief heat treatment, support removal, ultrasonic cleaning, and steam sterilization—with delivery to the operating room possible in as little as 72 hours. The first clinical application has been completed on an active-duty soldier with a large cranial defect caused by blast injury, and a 6-month postoperative CT follow-up showed good osseointegration. Value for powder purchasers: this is a strong signal that demand for medical-grade Ti-6Al-4V ELI powder is about to surge. The FDA case establishes a regulatory pathway template for point-of-care (PoC) implant manufacturing, which will accelerate approvals for PoC implants in other anatomical sites such as maxillofacial, spinal, and pelvic applications. Medical titanium powder demand will shift from centralized procurement to decentralized in-hospital needs—significantly expanding both market scale and the number of customers. This represents a definitive growth market for titanium powder suppliers.